Cargando…
Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal Transition
Jiedu Sangen Decoction (JSD), a traditional Chinese medicine (TCM) formula, has been widely used in China to treat gastrointestinal cancer, especially as an adjuvant therapy in colorectal cancer (CRC) patients. This study aimed to evaluate the efficacy of JSD and Jiedu Sangen aqueous extract (JSAE)...
Autores principales: | Zhang, Kai, Peng, Tao, Yan, Qingying, Sun, Leitao, Miao, Haojun, Yuan, Li, Hong, Yuxin, Zhou, Mengmeng, Guo, Kaibo, Zhang, Leyin, Fang, Jing, Shen, Minhe, Ruan, Shanming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176311/ https://www.ncbi.nlm.nih.gov/pubmed/30356400 http://dx.doi.org/10.1155/2018/1495768 |
Ejemplares similares
-
Inhibition to Epithelial-Mesenchymal Transition and Metastatic
Potential In Colorectal Cancer Cell By Combination of Traditional Chinese
Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor
por: Shan, Feiyu, et al.
Publicado: (2020) -
Jiedu Sangen Decoction Inhibits the Invasion and Metastasis of Colorectal Cancer Cells by Regulating EMT through the Hippo Signaling Pathway
por: Yuan, Li, et al.
Publicado: (2019) -
Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway
por: Yuan, Li, et al.
Publicado: (2019) -
Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum
por: Yuan, Li, et al.
Publicado: (2022) -
Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy
por: Zhang, Bo, et al.
Publicado: (2020)